News and Insights | Pharma, Clinical Trial Supply & Early Access

Environmental Sustainability and the Supply of Medicines for Use in Clinical Trials

Sustainability is more than a buzzword for companies in the clinical supplies industry. Learn more about the solutions to make a difference

Clinical Trial Services, Featured

Environmental Sustainability and the Supply of Medicines for Use in Clinical Trials

Sustainability is more than a buzzword for companies in the clinical supplies industry. Learn more about the solutions to make a difference

Early Access, Update

Meet Inceptua Early Access & Unlicensed Medicines 2024

Conference attendance: Meet Inceptua Early Access & Unlicensed Medicines 2024

Early Access, Featured

Practical Perspectives on Real-World Evidence in Early Access: Bridging the Gap between Hype and Reality

“Effectively Collect Real World Evidence for Early Access Programs”. We have asked Stuart a few questions to reflect on the topic …

Clinical Trial Services, Update

Meet Inceptua Clinical Trial Supply & Services

Clinical Trial Services, Update

Meet Inceptua CTS at GCSG in Athens

Clinical Trial Services, Featured

New web-based tool: Inceptua Site Order Portal help optimize clinical trials

Early Access, Featured

Guide to: Umbrella Access Programs (UAP)

Ask Inceptua, Early Access, Featured

The Critical role of Real-World Data in Orphan Drug Development and the Role of Early Access Programs

Ask Inceptua, Early Access, Featured

Early Access – bridging innovation and commercialization of therapies

Clinical Trial Services, Update

Inceptua Strengthening Presence in China

Early Access, Featured

When is an Early Access Program not the right option?

Early Access, Featured

Patient Forecasting in Early Access Programs

Early Access, Featured

When Early Access Programs Go Bad

Early Access, Featured

Is there a role for Ethics Committees in Early Access?

Early Access

Inceptua Q&A: What is Early Access?

Early Access, Featured, Press release

Inceptua Group Expands Early Access Program to Latin America

Featured, Press release

Cycle Pharmaceuticals and Inceptua Group Partner for a Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU)

Cycle Pharmaceuticals and Inceptua Group Partner for a Free Goods Programme

Featured, News

Inceptua welcomes Vesey Street Capital Partners as majority shareholder

Vesey Street Capital Partners, LLC has agreed to join us as investor and majority shareholder

News

Pharming Group and HAEi International announce partnership with Inceptua for HAEi Global Access Program

Featured, Press release

Inceptua Early Access and Sentynl Therapeutics Inc. Announce the Launch of the Early Access Program for Nulibry® (fosdenopterin)

Featured, Inceptua Pharma, Press release

Apealea® (paclitaxel micellar) is now available in Germany for the treatment of ovarian cancer

Featured, Press release

Vice President, Global Regulatory Affairs Joins Inceptua Early Access

Featured, News

Q&A with Mark Ware, Executive Vice President, Head of Inceptua Clinical Trial Supply

Featured, Press release

World-Leading Regulatory Affairs Expert Joins Inceptua Group

Featured, Inceptua Pharma, Press release

Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer

Clinical Trial Services, Featured Clinical Supply, News

Brexit and Clinical Trial Supply – Understand and Manage the Impact

Early Access, Featured, Press release

Inceptua strengthens early access division with key business development hire

Clinical Trial Services, Featured Clinical Supply, News

Assess and Manage Risks in the Clinical Trial Supply Chain

Featured, Inceptua Pharma, News

Oasmia announces transfer of Nordic commercialization rights for Apealea® (Paclitaxel Micellar) to Inceptua

Featured, Inceptua Pharma, Press release

Insights

News and Press Releases

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.